Uusia kasvaimen- ja leukemianvastaisia aineita, niiden valmistus ja niitä sisältäviä farmaseuttisia koostumuksia

PCT No. PCT/FR95/00814 Sec. 371 Date Dec. 19, 1996 Sec. 102(e) Date Dec. 19, 1996 PCT Filed Jun. 20, 1995 PCT Pub. No. WO96/00205 PCT Pub. Date Jan. 4, 1996(3-hydroxy-4-methoxybenzyl)-7-methylene-1-vinyl-2,3,3a,4,7,7a-hexahydroinden-4-one of formula (I): (I) and 3-(3-hydroxy-4-methoxybenzyl)-4-hydro...

Full description

Saved in:
Bibliographic Details
Main Authors LEBOUL, JEAN, PROVOST, JEAN
Format Patent
LanguageFinnish
Swedish
Published 21.02.1997
Edition6
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:PCT No. PCT/FR95/00814 Sec. 371 Date Dec. 19, 1996 Sec. 102(e) Date Dec. 19, 1996 PCT Filed Jun. 20, 1995 PCT Pub. No. WO96/00205 PCT Pub. Date Jan. 4, 1996(3-hydroxy-4-methoxybenzyl)-7-methylene-1-vinyl-2,3,3a,4,7,7a-hexahydroinden-4-one of formula (I): (I) and 3-(3-hydroxy-4-methoxybenzyl)-4-hydroxy-7-methyl-1-vinylindan of formula (II): (II) as well as their stereoisomeric forms are disclosed. Also disclosed are a process for producing these compounds from the plant Ottelia alismoides and pharmaceutical compositions containing them. The novel compounds of formulas (I) and (II) have remarkable antitumor and antileukaemic properties.
Bibliography:Application Number: FI19960005166